This fund gives investors exposure to the small cap health care industry, a market segment that has both value and growth characteristics. Securities in this corner of the market can be also be prone to quick shifts in sentiment thanks to changing government regulations or policies. Furthermore, many companies in this corner of the market are unprofitable and rely on FDA drug approval in order to snap back into the green, a very risky proposition. With that being said, PSCH gives investors a nice mix of biotech, pharma, medical tech, and facility companies spreading risk around the various corners of the health care world. However, it should be noted that the fund does still have singificant concentrattion in its top ten holdings as these companies make up close to one third of total assets, rather high considering the fund only has 70 securities in total. As a result, investors should consider this fund only if they are looking to tactically tilt towards the sector or round out exposure to the health care segment.
| Segment | Equity: U.S. Health Care |
| Category | Sector |
| Focus | Health Care |
| Niche | Broad-based |
| Strategy | Vanilla |
| Weighting Scheme | Market Cap |
This section compares how balanced and deep this ETF is relative to its peers.
| PSCH | ETF Database Category Average | FactSet Segment Average | |
|---|---|---|---|
| Number of Holdings | 74 | 81 | 136 |
| % of Assets in Top 10 | 35.46% | 45.68% | 43.79% |
| % of Assets in Top 15 | 47.68% | 58.67% | 55.76% |
| % of Assets in Top 50 | 88.69% | 93.21% | 91.52% |
| PSCH | ETF Database Category Average | FactSet Segment Average | |
|---|---|---|---|
| Large (>12.9B) | 0.00% | 54.29% | 66.71% |
| Mid (>2.7B) | 56.01% | 24.86% | 22.54% |
| Small (>600M) | 43.11% | 14.81% | 9.45% |
| Micro (<600M) | 0.79% | 5.35% | 0.64% |
This section compares the P/E ratio of this ETF to its peers.
This section compares the dividend yield of this ETF to its peers.
| PSCH | ETF Database Category Average | FactSet Segment Average | |
|---|---|---|---|
| Dividend | $ 0.02 | $ 0.27 | $ 0.24 |
| Dividend Date | 2024-12-23 | N/A | N/A |
| Annual Dividend Rate | $ 0.12 | $ 0.48 | $ 0.97 |
| Annual Dividend Yield | 0.28% | 0.78% | 0.82% |
View charts featuring PSCH price and volume data.
View charts featuring ETF fund flow data.
5 Day Net Flows: -1.71 M 1 Month Net Flows: -6.97 M 3 Month Net Flows: -11.15 M 6 Month Net Flows: -23.58 M 1 Year Net Flows: -60.94 M 3 Year Net Flows: -163.12 M 5 Year Net Flows: -306.26 M 10 Year Net Flows: -71.2 MView charts that break down the influence that fund flows and price had on overall assets.
5 Day Net AUM Change: -2.34 MThe adjacent table gives investors an individual Realtime Rating for PSCH on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETF Database Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETF Database Pro. To view information on how the ETF Database Realtime Ratings work, click here.
This section compares the cost efficiency of this ETF to its peers.
| Max ST Capital Gains Rate | 39.60% |
| Max LT Capital Gains Rate | 20.00% |
| Tax On Distributions | Qualified dividends |
| Distributes K1 | No |
This section shows how this ETF has performed relative to its peers. Returns over 1 year are annualized.
| PSCH |
ETF Database
Category Average |
Factset Segment
Average |
|
|---|---|---|---|
| 1 Month Return | -12.94% | -5.35% | -2.41% |
| 3 Month Return | -4.39% | 1.41% | 2.11% |
| YTD Return | -3.82% | 0.83% | 1.63% |
| 1 Year Return | -0.86% | -2.94% | -0.79% |
| 3 Year Return | -7.54% | -2.20% | 0.21% |
| 5 Year Return | 6.93% | 5.23% | 6.60% |
The following charts reflect the geographic spread of PSCH's underlying holdings.
| Region | Percentage |
|---|---|
| North, Central and South America | 99.99% |
| Other | 0.0% |
| Country | Percentage |
|---|---|
| United States | 96.2% |
| Ireland | 3.7% |
| Other | 0.09% |
The following charts reflect the allocation of PSCH's underlying holdings.
| Sector | Percentage |
|---|---|
| Health Technology | 70.3% |
| Health Services | 16.92% |
| Finance | 4.31% |
| Technology Services | 3.46% |
| Commercial Services | 2.24% |
| Distribution Services | 1.63% |
| Process Industries | 1.04% |
| Miscellaneous | 0.09% |
| CASH | 0.0% |
| Market Cap | Percentage |
|---|---|
| Mid | 56.01% |
| Small | 43.11% |
| Micro | 0.79% |
| Large | 0.0% |
| Region | Percentage |
|---|
| Asset | Percentage |
|---|---|
| Share/Common/Ordinary | 99.9% |
| Open-ended Fund | 0.09% |
| CASH | 0.0% |
| Sector | Percentage |
|---|---|
| Health Technology | 70.3% |
| Health Services | 16.92% |
| Finance | 4.31% |
| Technology Services | 3.46% |
| Commercial Services | 2.24% |
| Distribution Services | 1.63% |
| Process Industries | 1.04% |
| Miscellaneous | 0.09% |
| CASH | 0.0% |
This section shows how the volatility of this ETF compares to the peer group ETF Database Category.
| 5 Day Volatility | 140.17% |
| 20 Day Volatility | 28.06% |
| 50 Day Volatility | 24.42% |
| 200 Day Volatility | 24.63% |
| Beta | 1.0 |
| Standard Deviation | 2.04% |
ETF Database's Financial Advisor Reports are designed as an easy handout for clients to explain the key information on a fund. Includes new analyst insights and classification data.
Fact sheets are issued by the ETF provider and framed by ETF Database. Information contained within the fact sheet is not guaranteed to be timely or accurate.
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to...
Here is a look at the 25 best and 25 worst ETFs from the past year. Traders can use this list to...
Evan Harp sat down with Ignacio Canto, founder of X-Square Capital. They discussed their...
ETF Trends and ETF Database , the preeminent digital platforms for ETF news, research, tools, video, webcasts, native content channels, and more. The ETF Trends and ETF Database brands have been trusted amongst advisors, institutional investors, and individual investors for a combined 25 years. The firms are uniquely positioned to aid advisor’s education, adoption, and usage of ETFs, as well as the asset management community’s transition from traditionally analog to digital interactions with the advisor community.
Our team at ETF Database is committed to making our website the premier source of information on ETF investing with the world’s highest quality ETF tools, content, and resources.
ETF Database analysts have a combined 50 years in the ETF and Financial markets, covering every asset class and investment style. The team monitors new filings, new launches and new issuers to make sure we place each new ETF in the appropriate context so Financial Advisors can construct high quality portfolios.
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
A long-running debate in asset allocation circles is how much of a portfolio an investor should...
In a digital age where information moves in milliseconds and millions of participants can transact...